Gilead’s RA Hopeful Filgotinib Hit By Complete Response Letter

FDA Concerned About High Dose And Testicular Side Effects

 
• By Andrew McConaghie

Complete Response Letter is a major setback for Gilead and its partner Galapagos.  

two hands of an elderly woman sitting on a chair - Image
• Source: Shutterstock

More from Business

More from Scrip